LANTHEUS' LOW-ENRICHED URANIUM (LEU)
Innovative LEU TechneLite® Generator Meets CMS Criteria for
Tc-99m Add-on Payment
LEU TechneLite® (Technetium Tc 99m Generator) is a technetium-99m (Tc-99m) generator that provides the essential medical isotope used by hospitals and radiopharmacies to radiolabel a variety of radiopharmaceuticals requiring Tc-99m, which are used in critical diagnostic imaging tests. Lantheus received FDA approval for the commercial use of LEU in 2010 and has used a blend of Highly Enriched Uranium (HEU) and LEU molybdenum-99 (Mo-99) in its TechneLite® generators in the U.S. market since 2011. In January 2013, LEU TechneLite® became the first Tc-99m generator in the United States that contains at least 95 percent non-HEU-sourced Mo-99 that meets the Centers for Medicare and Medicaid Services (CMS) criteria for the incremental add-on Hospital Outpatient Prospective Payment System (HOPPS) payment. With greater access to LEU Mo-99 through its supply chain diversification strategy, Lantheus can now move closer to its goal of eventually eliminating HEU-sourced Mo-99 from its supply chain. Read More
As a leader in the radiopharmaceutical business, Lantheus has developed a world class, globally diversified and balanced Molybdenum-99 (Mo-99) supply chain for the procurement of Mo-99. The company receives Mo-99 from four of the five major processors and seven of the eight associated reactors. As the industry moves toward Low-Enriched Uranium (LEU)-based Mo-99 supply, Lantheus' introduction of the LEU TechneLite® generator and gradual conversion to 100 percent LEU-derived Mo-99 ensures that our customers will have access to Technetium Tc-99m, now and in the future.
References: 1. National Nuclear Security Administration - U.S. Department of Energy, 2010. First LEU-Produced Molybdenum-99 Approved for Patient Use Arrives in U.S. [press release], 6 December 2010, Available at: <http://www.nnsa.energy.gov/mediaroom/pressreleases/leumoly120610> [Accessed 30 July 2012]
2. Lantheus Medical Imaging, 2010. Lantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99. [press release], 6 December 2012, Available at: <http://www.lantheus.com/News-Press-2010-1206.html> [Accessed 30 July 2012]